We investigated the antioxidant action of a solid preparation of Xingnaojing (XNJ) and ascorbic acid (AA) in stroke-prone spontaneously hypertensive rats (SHRSP). The total antioxidant states in the plasma, systolic blood pressure, and heart rate were measured every 2 weeks, and lipid peroxidation, expressed as thiobarbituric acid-reactive substances in plasma, was measured in the 6th week. The results showed that AA and XNJ significantly increased the total antioxidant status in plasma and reduced malondialdehyde in the plasma. These data suggest that during 6-week administration, XNJ has antioxidant action on SHRSP, which may relate to its generalized inhibition of lipid peroxidation and promotion of the total antioxidant state. These results demonstrated that orally treated XNJ has an antioxidant effect on SHRSP plasma.
XNJ consists of Chinese herbs such as Moschus, Borneol, Radix Curcumae and Fructus Gardniae. XNJ preparations are commonly applied for cerebral ischemia in Chinese clinics [1a] . Previous reports suggested that XNJ injection is effective for cerebral edema and the blood-brain barrier in rats following traumatic brain injury [2, 3] . We are therefore interested in the effect of ROS in XNJ treatment. ROS such as superoxide anions and hydroxyl radicals are implicated in the pathogenesis of hypertension [4, 5] .
The production of superoxide anions is increased in SHRSP [4, 6] . We previously reported that chronic ingestion of a chemical compound from plant, sesamin, and vitamin C attenuated oxidative stress in SHRSP [7] . Thus, we hypothesized that chronic treatment with XNJ may have antioxidant action in SHRSP, and this effect attenuated brain damage. The purpose of this study was to determine whether orally administerd XNJ can attenuate oxidative stress in SHRSP in vivo. http://circ.ahajournals.org/content/109/19/ 2357.long -ref-1#ref-1
Before starting the experiment on SHRSP rats, we measured the total antioxidant power of XNJ in vitro. Total antioxidant capacity was 2.96 ± 0.23 and 6.16 ± 1.43 nmol Cu ++ reduction (n = 3) in 0.2 and 0.4 mg/mL XNJ water while water only was not detected. The plasma total antioxidant state (TAS) was designed to evaluate the overall performance of the antioxidant system. Plasma TAS of SHRSP, in AA group, XNJ(H) group, and AA+XNJ(H) group significantly increased in the 2nd week of medication. In the 4th week, TAS in the AA group and AA+XNJ(H) group significantly increased, although plasma TAS in XNJ-treated groups, XNJ(M) and XNJ(H), mildly increased. In the 6th week, plasma TAS in XNJ(H) group and AA+XNJ(H) group significantly increased SHRSP showed the increased in TAS between 2nd and 6th week treatment. ROS production was increased in SHRSP with age. Increased levels of ROS in SHRSP may act as a signal to enhance the activity and expression of antioxidant enzymes. This being an adaptation to help cells and tissues protect from oxidative stress ( Figure 1 ). Control group rats received as a salty diet(4%w/w), AA group rats were treated with ascorbic acid (AA, 1000 mg/d), XNJ(M) group rats were treated with XNJ (2.5 mg/100 gBW), XNJ(H) group rats were treated with XNJ (5.0 mg), and AA+ XNJ(H) group were treated with AA(1000 mg/d) + XNJ(5.0 mg/100g). All rats were given a salty diet for 6 weeks. Control group rats received as a salty diet, AAgroup rats were treated with ascorbic acid (AA, 1000 mg/d), XNJ(M) group rats were treated with XNJ(2.5 mg/100 gBW), XNJ(H) group rats were treated with XNJ (5.0 mg/100 g), and AA+ XNJ(H) group rats were treated with AA (1000 mg/d) + XNJ g/100 g). All rats were given a salty diet (4 gw/w) during the 6-week treatment. *; P<0.05, **; P<0.01 vs. control group.
malondialdehyde (MDA) in the XNJ(H) group and the AA+XNJ group significantly was decreased compared with the control in the 6th week (Figure 2 ). There are many reports that XNJ can reduce brain injury and enhance functional recovery after traumatic brain injury and stroke in animal models of injury [1b,1d]. SHRSP is regarded as a useful model of human hypertensive encephalopathy, characterized by cerebral hemorrhage and infarction, and is extensively used to study the effect of drugs on stroke. The brain is considered highly vulnerable to oxidative stress as it consumes a high amount of oxygen and contains a high amount of polyunsaturated fatty acids and a low level of antioxidant enzyme. Some reports suggest that brain infarction may be related to oxidative stress [8, 9] . We therefore studied the effect of oxidative stress in plasma on XNJ, which is usually administered by intravenous injection. In the present study, we show that oral treatment of XNJ increased TAS and decreased MDA in plasma. XNJ has antioxidant action in SHRSP, which might relate to its generalized inhibition of lipid peroxidation. In the combination of AA and XNJ, the protective effects of XNJ were as effective as AA, which may be due to the synergistically effect of antioxidative power. We suggest that oral exposure to XNJ caused a significant decrease in oxidative stress in the plasma of SHRSP.
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In conclusion, these data suggest that during 6-week administration, XNJ had antioxidant action on SHRSP, which may relate to its generalized inhibition of lipid peroxidation and promotion of TAS. Further study on its mechanism is necessary.
Experimental
Total antioxidant power of XNJ in vitro: The antioxidant power of biological fluids can be evaluated by measuring total antioxidant capacity (TAC). XNJ was diluted with water at 0.2 and 0.4 mg/mL. TAC was measured by Total Antioxidant Capacity Assay Kit (BioVision, San Diego,CA, USA).
Animals and Experimental Protocol:
Male SHRSP rats were provided by the Disease Model Cooperative Research Association (Kyoto, Japan), for which all protocols were approved by the School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University. All rats were housed under controlled conditions of constant temperature (22°C) and a light/dark cycle of 12 h with free access to food and water for one week. Twenty-five male SHRSP, 6 weeks of age, were divided into five groups: control group rats served as a salty diet, AA group rats were treated with ascorbic acid (AA, 1000 mg/d), XNJ(M) group rats were treated with XNJ (2.5 mg/100 g BW), XNJ(H) group rats were treated with XNJ (5.0 mg/100 g), and AA+ XNJ(H) group rats were with XNJ (5.0 mg/100 g), and AA(1000 mg/d). All rats were given a salty diet (4% w/w) during the 6-week treatment. XNJ was given orally in the morning for 6 weeks. XNJ was obtained from Wui Jimingkexing Shanhe Pharceutic Co, Ltd. China, batch number: 061233). During the experiment, SBP and HR were measured by the tail-cuf method as previously described [10] . The median of five successive measurements was used. After 6-week treatment with XNJ, the rats were sacrificed, and blood samples were collected from the abdominal vein with heparin.
Detection of oxidative stress in XNJ-treated SHRSP: Blood was collected for plasma samples from the tail vein, which was kept at -80 degrees for detection of TAS every two weeks. TAS was detected using TAS kit (Randox, Antrim, UK). Generation of lipid peroxidation: The content of MDA in plasma was measured with a thiobarbituric acid-reactive substance kit (Cayman, Ann Arbor, MI, USA). Blood was obtained from the vena cava in control, AA, XNJ(H) and AA+ XNJ(H) groups.
Statistical analysis: Statistical analysis was performed by multifactor analysis of variance (ANOVA) and the LSD test. All data are expressed as the mean ± SD.
